Identity
HGNC
LOCATION
Xp11.23
LOCUSID
ALIAS
CDG2M,CDGX,UDP-Gal-Tr,UGALT,UGAT,UGT,UGT1,UGT2,UGTL
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 7355
MIM: 314375
HGNC: 11022
Ensembl: ENSG00000102100
Variants:
dbSNP: 7355
ClinVar: 7355
TCGA: ENSG00000102100
COSMIC: SLC35A2
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38143314 | 2024 | SLC35A2 expression drives breast cancer progression via ERK pathway activation. | 1 |
| 38143314 | 2024 | SLC35A2 expression drives breast cancer progression via ERK pathway activation. | 1 |
| 36307217 | 2023 | Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the SLC35A2 Gene. | 7 |
| 36454514 | 2023 | Nucleotide sugar transporter SLC35A2 is involved in promoting hepatocellular carcinoma metastasis by regulating cellular glycosylation. | 6 |
| 36933771 | 2023 | SLC35A2 deficiency reduces protein levels of core 1 β-1,3-galactosyltransferase 1 (C1GalT1) and its chaperone Cosmc and affects their subcellular localization. | 0 |
| 37739137 | 2023 | SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE. | 0 |
| 36307217 | 2023 | Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the SLC35A2 Gene. | 7 |
| 36454514 | 2023 | Nucleotide sugar transporter SLC35A2 is involved in promoting hepatocellular carcinoma metastasis by regulating cellular glycosylation. | 6 |
| 36933771 | 2023 | SLC35A2 deficiency reduces protein levels of core 1 β-1,3-galactosyltransferase 1 (C1GalT1) and its chaperone Cosmc and affects their subcellular localization. | 0 |
| 37739137 | 2023 | SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE. | 0 |
| 33407896 | 2021 | Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE). | 32 |
| 34161696 | 2021 | SLC35A2-CDG: novel variants with two ends of the spectrum. | 0 |
| 34384782 | 2021 | A three-pocket model for substrate coordination and selectivity by the nucleotide sugar transporters SLC35A1 and SLC35A2. | 2 |
| 33407896 | 2021 | Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE). | 32 |
| 34161696 | 2021 | SLC35A2-CDG: novel variants with two ends of the spectrum. | 0 |
Citation
Dessen P
SLC35A2 (solute carrier family 35 member A2)
Atlas Genet Cytogenet Oncol Haematol. 2014-11-01
Online version: http://atlasgeneticsoncology.org/gene/73398/slc35a2-(solute-carrier-family-35-member-a2)
